CS6591A3 - Method of protein production with antibody activity - Google Patents

Method of protein production with antibody activity

Info

Publication number
CS6591A3
CS6591A3 CS9165A CS6591A CS6591A3 CS 6591 A3 CS6591 A3 CS 6591A3 CS 9165 A CS9165 A CS 9165A CS 6591 A CS6591 A CS 6591A CS 6591 A3 CS6591 A3 CS 6591A3
Authority
CS
Czechoslovakia
Prior art keywords
antibody activity
protein production
protein
microinjection
rabbit
Prior art date
Application number
CS9165A
Other languages
English (en)
Inventor
Gottried Prof Dr Dr Med V Brem
Original Assignee
Brem Gottfried
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brem Gottfried filed Critical Brem Gottfried
Publication of CS6591A3 publication Critical patent/CS6591A3/cs
Publication of CZ289553B6 publication Critical patent/CZ289553B6/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/107—Rabbit
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/108—Swine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
CS199165A 1990-01-15 1991-01-14 Způsob výroby bílkovin s účinností protilátek CZ289553B6 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4000939A DE4000939A1 (de) 1990-01-15 1990-01-15 Verfahren zur antikoerpergewinnung

Publications (2)

Publication Number Publication Date
CS6591A3 true CS6591A3 (en) 1991-09-15
CZ289553B6 CZ289553B6 (cs) 2002-02-13

Family

ID=6398081

Country Status (12)

Country Link
US (1) US5639457A (cs)
EP (1) EP0438102B1 (cs)
JP (1) JPH0570499A (cs)
AT (1) ATE244761T1 (cs)
AU (1) AU627099B2 (cs)
CA (1) CA2034034C (cs)
CZ (1) CZ289553B6 (cs)
DE (2) DE4000939A1 (cs)
HU (1) HU218047B (cs)
LV (1) LV10790B (cs)
PL (2) PL171474B1 (cs)
RU (1) RU2095412C1 (cs)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0463151T3 (da) * 1990-01-12 1996-07-01 Cell Genesys Inc Frembringelse af xenogene antistoffer
US5827690A (en) * 1993-12-20 1998-10-27 Genzyme Transgenics Corporatiion Transgenic production of antibodies in milk
US6335160B1 (en) * 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US20040054593A1 (en) * 1997-03-21 2004-03-18 Van Luchen Andrew S. Method and apparatus for facilitating the play of fractional lottery tickets utilizing point-of -sale terminals
WO2001035735A1 (en) * 1999-11-19 2001-05-25 Hematech, Llc Production of ungulates, preferably bovines that produce human immunoglobulins
US7414170B2 (en) * 1999-11-19 2008-08-19 Kirin Beer Kabushiki Kaisha Transgenic bovines capable of human antibody production
US7820878B2 (en) * 1999-11-19 2010-10-26 Kyowa Hakko Kirin Co., Ltd. Production of ungulates, preferably bovines that produce human immunoglobulins
US7074983B2 (en) * 1999-11-19 2006-07-11 Kirin Beer Kabushiki Kaisha Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin
AU2000265672A1 (en) 2000-07-27 2002-02-13 Apogene Gmbh And Co. Kg Somatic cloning gene transfer for the production of recombinant proteins, cells and organs
IL154751A0 (en) 2000-08-03 2003-10-31 Humanized antibodies, recombination vectors, transgenic vectors and methods for the preparation of humanized antibodies from transgenic animals
US20020142397A1 (en) * 2000-12-22 2002-10-03 Philippe Collas Methods for altering cell fate
NZ525607A (en) 2000-12-22 2005-05-27 Aurox Llc Methods for cloning mammals using reprogrammed donor chromatin or donor cells
US7491534B2 (en) * 2000-12-22 2009-02-17 Kirin Holdings Kabushiki Kaisha Methods for altering cell fate to generate T-cells specific for an antigen of interest
EP1563084A4 (en) 2002-11-08 2006-03-01 Hematech Llc TRANSGENE UNGULATES WITH REDUCED PRION PROTEIN ACTIVITY AND USES THEREOF
US7514593B2 (en) * 2003-05-30 2009-04-07 The University Of North Carolina At Chapel Hill Animal model for chronic obstructive pulmonary disease and cystic fibrosis
CA2563064A1 (en) 2004-04-22 2005-11-10 Kirin Beer Kabushiki Kaisha Transgenic animals and uses thereof
CA2568201C (en) 2004-05-24 2013-07-30 Universitat Zu Koln Identification of ergothioneine transporter and therapeutic uses thereof
RU2303068C1 (ru) * 2005-10-31 2007-07-20 Всероссийский государственный научно-исследовательский институт животноводства (ВИЖ) Способ введения ретровирусных векторов в клетки бластодермы при получении трансгенных кур
US8124831B2 (en) * 2006-07-06 2012-02-28 Duke University Transgenic mice carrying functional single nucleotide polymorphisms in brain-specific tryptophan hydroxylase
ATE536374T1 (de) 2006-09-01 2011-12-15 Therapeutic Human Polyclonals Inc Erhöhte expression von humanem oder humanisiertem immunglobulin bei nicht-humanen transgenen tieren
KR101722961B1 (ko) 2009-02-11 2017-04-04 알부메딕스 에이/에스 알부민 변이체 및 접합체
ES2700230T3 (es) 2009-10-30 2019-02-14 Albumedix Ltd Variantes de albúmina
US10233228B2 (en) 2010-04-09 2019-03-19 Albumedix Ltd Albumin derivatives and variants
US20140315817A1 (en) 2011-11-18 2014-10-23 Eleven Biotherapeutics, Inc. Variant serum albumin with improved half-life and other properties
DK2825556T3 (en) 2012-03-16 2018-04-16 Albumedix As albumin Variants
RU2670063C2 (ru) 2012-11-08 2018-10-17 Альбумедикс А/С Варианты альбумина
US10034921B2 (en) 2013-02-13 2018-07-31 Laboratoire Français Du Fractionnement Et Des Biotechnologies Proteins with modified glycosylation and methods of production thereof
BR112015019341A2 (pt) 2013-02-13 2017-08-22 Lab Francais Du Fractionnement Anticorpo anti-tnf-alfa, composição que compreende o anticorpo, método para produzir uma população de anticorpos, células epiteliais da glândula mamária, mamífero não humano transgênico, e, composição de anticorpo anti-tnf monoclonal
EP2956002B1 (en) * 2013-02-16 2017-09-06 Albumedix A/S Pharmacokinetic animal model
FR3038517B1 (fr) 2015-07-06 2020-02-28 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Utilisation de fragments fc modifies en immunotherapie
EP3337816B1 (en) 2015-08-20 2024-02-14 Albumedix Ltd Albumin variants and conjugates
US11266129B2 (en) 2019-11-05 2022-03-08 Versiti Blood Research Institute Foundation, Inc. Murine model of fetal/neonatal alloimmune thrombocytopenia
JP2023500896A (ja) 2019-11-05 2023-01-11 ヴァーシティ ブラッド リサーチ インスティテュート ファウンデーション， インコーポレイテッド 胎児／新生児同種抗体血小板減少症のマウスモデル
WO2024261097A1 (en) 2023-06-20 2024-12-26 Institut National de la Santé et de la Recherche Médicale A new relevant non-human animal model of progressive metabolic dysfunction-associated steatotic liver disease (masld) and atherosclerosis development

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0088994B1 (en) * 1982-03-15 1991-06-19 Schering Corporation Hybrid dna, binding composition prepared thereby and processes therefor
US4870009A (en) * 1982-11-22 1989-09-26 The Salk Institute For Biological Studies Method of obtaining gene product through the generation of transgenic animals
JPS6242933A (ja) * 1985-04-10 1987-02-24 Teijin Ltd 水痘帯状疱疹ウイルスに対するヒト型モノクロ−ナル抗体及びその製造法
GB8823869D0 (en) * 1988-10-12 1988-11-16 Medical Res Council Production of antibodies

Also Published As

Publication number Publication date
HUT58819A (en) 1992-03-30
JPH0570499A (ja) 1993-03-23
DE4000939A1 (de) 1991-07-18
CA2034034A1 (en) 1991-07-16
LV10790A (lv) 1995-08-20
US5639457A (en) 1997-06-17
PL170647B1 (pl) 1997-01-31
RU2095412C1 (ru) 1997-11-10
AU6867491A (en) 1991-11-14
DE59109255D1 (de) 2003-08-14
AU627099B2 (en) 1992-08-13
CZ289553B6 (cs) 2002-02-13
HU218047B (hu) 2000-05-28
EP0438102A1 (de) 1991-07-24
EP0438102B1 (de) 2003-07-09
HU910094D0 (en) 1991-08-28
PL171474B1 (pl) 1997-05-30
ATE244761T1 (de) 2003-07-15
LV10790B (en) 1996-06-20
CA2034034C (en) 2004-06-01

Similar Documents

Publication Publication Date Title
CS6591A3 (en) Method of protein production with antibody activity
ES2210281T3 (es) Produccion transgenica de anticuerpos en la leche.
NL300118I1 (nl) Voor Factor VIIIC coderende DNA-sequenties en verwante DNA-constructen.
ATE260974T1 (de) Transgenes, nicht-menschliches säugetier das die amyloidbildende pathologie der alzheimerschen krankheit zeigt
LU91756I2 (fr) Denosumab
DE3888337D1 (de) Verfahren zur gentechnischen Herstellung von Antikörpern.
DK0527063T3 (da) Produktion af et protein af interesse i mælken af et transgent pattedyr
EP0270248A3 (en) Dna useful for the transport of foreign proteins to the plant cell wall
AU1831097A (en) Thyroid sodium/iodide symporter and nucleic acid encoding same
JPS55131399A (en) Cultivation of namalva cell and replacing animal serum protein by human albumine for producing interferon by said cell
DE3852582D1 (de) Verfahren zur Präparation von stabilen Zellinien aus transgenen Tieren zur Herstellung bestimmter Proteine, Tumorzellinien und daraus erhaltene Proteine.
DE59108128D1 (de) Verfahren zur Herstellung von Fremdproteinen in Streptomyceten
ES2100340T3 (es) Antigeno peptidico de cdw52 sintetico (campath-1).
ZA823339B (en) Purification or enrichment of biologically active proteins and agent therefor
IL93024A0 (en) Introduction of exogenous dna into somatic and germ animal cells
MX9603266A (es) Genes de timocina de mamiferos.
Brem et al. Process for the production of antibodies
ES8405842A1 (es) Procedimiento de producir razas estables de celulas de mamiferos
CU22335A3 (es) Procedo para la produccion de anticuerpos
AR241658A1 (es) Procedimiento para la preparacion de una proteina que consiste de aminoacidos geneticamente codificables.
EP0603393A4 (en) RECOMBINANT HUMANES INTERLEUKIN-6 WITH HOMOGENEOUS N-TERMINUS AND ITS PRODUCTION.
Pénit et al. Purification and properties of chick terminal deoxynucleotidyl transferase (TdT)
ES2146666T3 (es) Procedimiento para la obtencion recombinante de proteinas en levadura.
ATE92962T1 (de) Mikrobiologisches verfahren zur gewinnung eines proteins durch zuechtung eines mutanten bakterienstammes.

Legal Events

Date Code Title Description
PD00 Pending as of 2000-06-30 in czech republic
MM4A Patent lapsed due to non-payment of fee

Effective date: 20050114